VivoPower International (VVPR) has released an update.
VivoPower International PLC has announced a preliminary agreement with Sansure Biotech Inc to distribute Mpox diagnostic tests in Singapore, Hong Kong, and Australia, as part of their business continuity planning to protect employees and support partners and customers. This agreement aligns with VivoPower’s commitment as a B Corporation to the triple bottom line of People, Planet, and Profit, and plans to contribute any profits from the distribution towards its core sustainable energy solutions business. The initiative also includes pro bono distribution to disadvantaged communities, supported by contributions from VivoPower’s executive team.
For further insights into VVPR stock, check out TipRanks’ Stock Analysis page.
